Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMU03WD)

Drug Name

IO-202 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 1	[1]
Chronic myelomonocytic leukaemia	2A40	Phase 1	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Leukocyte immunoglobulin-like receptor B4 (LILRB4)	TTREOKA	LIRB4_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04372433) IO-202 as Monotherapy in Patients in AML and CMML. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Immune-Onc Therapeutics.